/ /


Pre-operative measurements important in IOL decision-makingSurgeons work hard to get happy patients, and satisfied patients spread the word and refer their friends. They don't need extra post-op visits, and can return yearly to see their referring doctor. Selecting the best presbyopia-correcting IOL for a patient is critical and depends on methodical, preoperative decision-making.
PALADIN subset finds improvement after 12 months with intravitreal implantAmong a subset of patients in the phase IV PALADIN study, there was improved visual acuity, improved macular thickness, and reduced treatment burden among patients treated with the intravitreal fluocinolone acetonide 0.2 µg (Iluvien implant) for DME.
Intraop wavefront aberrometry may enhance results in toric IOL surgeryFindings of a study determining the prediction error in the magnitude of residual astigmatism after cataract surgery with a toric intraocular lens (IOL) suggest that use of intraoperative wavefront aberrometry for toric power selection could enhance the refractive outcome in a large subset of eyes.
Does dexamethasone implant add benefit in ranibizumab patients?The addition of dexamethasone implant (Ozurdex, Allergan) to a continuing regimen of ranibizumab (Lucentis, Genentech) did not produce results in visual acuity outcomes that differed from those achieved with ranibizumab alone at 6 months. However, there was an improvement in the central macular thickness on OCT in patients.
Distinction between lamellar holes and macular pseudoholesLamellar holes usually don’t require treatment, but it is important to recognize the eyes that may benefit from vitrectomy.
Drug delivery systems could improve poor adherenceJonathan S. Myers, MD, reports that intraocular drug delivery systems could help solve the problem of poor adherence in patients taking glaucoma medications. Implanted in the eye, the systems would allow for glaucoma drugs to gradually dissolve or elute medication.
Latest tonometry devices all have their pluses and minusesYvonne Buys, MD, says ophthalmologists can choose from a range of the latest devices for measuring IOP, each with its own strengths and weaknesses. While new technology continues to emerge, Dr. Buys provides an overview of tonometer technology.
Aflibercept shows macular perfusion gains in VISTA subanalysisThe use of aflibercept led to greater improvement in macular perfusion status in a phase III trial with DME patients. Those with baseline nonperfusion tended to have more advanced disease.
Respect patients' trust during eyewear selection
Respect patients' trust during eyewear selectionBuild a rapport with patients and understand they are placing trust in staffers when choosing new glasses. Tami Hagemeyer, ABOC, FNAO, offers suggestions to maximize patients' satisfaction with the process.
AMD trial data are highlights at recent conferencesClinical trial data focusing on treatment for age-related macular degeneration (AMD) have been a highlight at many recent ophthalmology meetings. Here are a few of the latest clinical trials that physicians need to be aware.


View Results